How India’s drug regulatory regime can ensure greater credibility for our pharma industry
The Ministry of Health should consider amending the Drugs and Cosmetics Act (1940) and instituting a centralised drugs database to enable effective surveillance across all pharmaceutical manufacturers. (Express Photo) It must move from being …